OA08494A - New polypeptides, their method of obtaining, monoclonal antibodies specific for these polypeptides, and use of these polypeptides. - Google Patents

New polypeptides, their method of obtaining, monoclonal antibodies specific for these polypeptides, and use of these polypeptides.

Info

Publication number
OA08494A
OA08494A OA59026A OA59026A OA08494A OA 08494 A OA08494 A OA 08494A OA 59026 A OA59026 A OA 59026A OA 59026 A OA59026 A OA 59026A OA 08494 A OA08494 A OA 08494A
Authority
OA
OAPI
Prior art keywords
polypeptides
obtaining
monoclonal antibodies
antibodies specific
new
Prior art date
Application number
OA59026A
Other languages
French (fr)
Inventor
Joyce M Zarling
Mohammed Shoyab
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Browm
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of OA08494A publication Critical patent/OA08494A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
OA59026A 1985-12-20 1986-12-19 New polypeptides, their method of obtaining, monoclonal antibodies specific for these polypeptides, and use of these polypeptides. OA08494A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (1)

Publication Number Publication Date
OA08494A true OA08494A (en) 1988-07-29

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59026A OA08494A (en) 1985-12-20 1986-12-19 New polypeptides, their method of obtaining, monoclonal antibodies specific for these polypeptides, and use of these polypeptides.

Country Status (29)

Country Link
JP (1) JP2559035B2 (en)
KR (1) KR920005920B1 (en)
CN (1) CN1017626B (en)
AT (1) AT400444B (en)
AU (2) AU601168B2 (en)
BE (1) BE905957A (en)
CA (1) CA1340296C (en)
CH (1) CH675727A5 (en)
CY (1) CY1608A (en)
DE (2) DE3645095C2 (en)
DK (1) DK174094B1 (en)
ES (1) ES2003180A6 (en)
FI (1) FI91484C (en)
FR (1) FR2597108B1 (en)
GB (1) GB2185485B (en)
GR (1) GR862936B (en)
HK (1) HK65691A (en)
HU (1) HU210694B (en)
IE (1) IE59415B1 (en)
IL (1) IL81017A (en)
IT (1) IT1213428B (en)
LU (1) LU86718A1 (en)
NL (1) NL8603209A (en)
NO (1) NO174556C (en)
NZ (1) NZ218634A (en)
OA (1) OA08494A (en)
PT (1) PT83986B (en)
SE (1) SE505059C2 (en)
SG (1) SG60891G (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Anti-oncostatin m monoclonal antibodies their preparation and pharmaceutical compositions containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
CY1608A (en) 1992-04-03
FI91484C (en) 1994-07-11
CH675727A5 (en) 1990-10-31
DE3645095C2 (en) 1993-11-18
NO174556B (en) 1994-02-14
HU210694B (en) 1995-06-28
JP2559035B2 (en) 1996-11-27
FI91484B (en) 1994-03-31
GB2185485B (en) 1990-07-04
SE8605459L (en) 1987-06-21
GR862936B (en) 1987-10-28
IT8622787A0 (en) 1986-12-19
LU86718A1 (en) 1988-07-14
AU6660886A (en) 1987-06-25
DE3643428A1 (en) 1987-09-24
KR920005920B1 (en) 1992-07-24
DE3643428C2 (en) 1990-08-23
PT83986B (en) 1989-07-31
AU6776590A (en) 1991-03-14
SG60891G (en) 1991-08-23
DK174094B1 (en) 2002-06-10
CA1340296C (en) 1998-12-29
AT400444B (en) 1995-12-27
KR870005645A (en) 1987-07-06
JPS62236498A (en) 1987-10-16
SE8605459D0 (en) 1986-12-18
BE905957A (en) 1987-06-17
IL81017A (en) 1993-01-14
DK615386D0 (en) 1986-12-18
IL81017A0 (en) 1987-03-31
FI865156A (en) 1987-06-21
FI865156A0 (en) 1986-12-17
SE505059C2 (en) 1997-06-16
CN1017626B (en) 1992-07-29
IT1213428B (en) 1989-12-20
NZ218634A (en) 1991-06-25
ATA340686A (en) 1995-05-15
FR2597108B1 (en) 1991-02-15
NO865178D0 (en) 1986-12-19
GB8629997D0 (en) 1987-01-28
IE863345L (en) 1987-06-20
HK65691A (en) 1991-08-23
ES2003180A6 (en) 1988-10-16
FR2597108A1 (en) 1987-10-16
AU639048B2 (en) 1993-07-15
NO174556C (en) 1994-05-25
AU601168B2 (en) 1990-09-06
IE59415B1 (en) 1994-02-23
CN86108955A (en) 1987-12-02
GB2185485A (en) 1987-07-22
PT83986A (en) 1987-01-01
NO865178L (en) 1987-06-22
NL8603209A (en) 1987-07-16
HUT43103A (en) 1987-09-28
DK615386A (en) 1987-06-21

Similar Documents

Publication Publication Date Title
OA06717A (en) DNA sequences, recombinant DNA molecule and method for the production of human interferon-like polypeptides.
MA20292A1 (en) New 2,2 '-iminobisethanol derivatives, intermediates for their preparation and processes for the preparation of these derivatives and intermediates.
FR2522679B1 (en) PROCESS FOR THE PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES
BE876277A (en) ANCHORING CONSTRUCTION FOR PRE-STRESSING ELEMENTS
OA08444A (en) New cephemes and processes for their preparation.
DK603287D0 (en) DRAWING OF METAL FOR NECK WHEN CONTENTS ARE UNDER COVERED
OA08168A (en) Monoclonal anti-leishmania antibodies, hybridomas secreting these antibodies, leishmania antigens recognized by these anticoprs, process for obtaining and applications of these monoclonal antibodies and of these antigens.
NO870649D0 (en) PROCEDURE FOR MASS POLYMERIZATION OF BUTADIA.
OA08494A (en) New polypeptides, their method of obtaining, monoclonal antibodies specific for these polypeptides, and use of these polypeptides.
OA06201A (en) Process for the preparation of new compounds of urea and amido.
OA07341A (en) New oximethers, process for their preparation, agents containing the new oximethers and their application.
PT86117A (en) ANTIGRAM (-) MONOCLONAL ANTIBODIES, PROCESS FOR PREPARATION AND APPLICATIONS
FR2597010B1 (en) LIQUID APPLICATOR HAVING IMPROVED LIQUID INTRODUCING MEANS
FR2647346B1 (en) STABILIZED PROGESTERONE COMPOUND, PROCESS FOR PREPARING THE SAME, AND USE OF THE COMPOUND FOR OBTAINING A MEDICAMENT
FR2589228B1 (en) DEVICE FOR THE CONTINUOUS DEVELOPMENT OF MATERIALS OBTAINED FROM SUBSTANCES IN THE MOLTEN STATE
BE854703A (en) BITUMOUS MASS-DYED MATERIALS IN PARTICULAR COVERING, SIDING OR SEALING MATERIALS AND PROCESS FOR THEIR OBTAINING
SE468853B (en) NEW Lymphokine, Monoclonal Antibodies Specific Species for Lymphokine and Their Preparation and Uses
OA06094A (en) Process for obtaining alkylthiosulphates and alkylidènethiosulphates.
BE893174A (en) NOVEL AMINODERIVES IN POSITION 1 OF 1- (3 ', 4'-METHYLENE-DIOXYPHENYL) PROPAN-2-OL AND PROCESS FOR THEIR PREPARATION
FR2549726B1 (en) FACTORS INCREASING THE FORMATION OF HUMAN ANTIBODIES AND PROCESS FOR THEIR PREPARATION
PT81194A (en) PROCESS FOR THE PREPARATION OF NEW HYDROXY-THIA ALKENES
MC1754A1 (en) NOVEL FLUORINATED SURFACTANTS DERIVED FROM PROTEIN MATERIALS: THEIR PROCESS FOR OBTAINING AND THEIR USE
FR2570947B1 (en) MONOCLONAL ANTI-LEISHMANIA ANTIBODIES, SECRET HYBRIDOMAS THEREOF, LEISHMANIA ANTIGENS RECOGNIZED BY THESE ANTIBODIES, PROCESS FOR OBTAINING AND APPLICATIONS THEREOF
OA08257A (en) New carboxamidoguanidines, their process for obtaining and pharmaceutical compositions containing them.
RO80055A2 (en) ANTIACNEIC, ANTISEBOREIC AND ANTIACTINIC DRUG COMPOSITION AND METHOD OF OBTAINING